Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | PRCP | P42785 | 2/20 | 0.35 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7982359 | 0.85 | BCHE (0.41) | SLC6A2SLC6A3ADRA1DADRA1AADRA1B | |
| SCHEMBL7977969 | 0.85 | SLC6A2 (0.36) | SLC6A2SLC6A3CARM1PRMT6ADRA1D | |
| SCHEMBL7977968 | 0.85 | SLC6A2 (0.36) | SLC6A2SLC6A3CARM1PRMT6ADRA1D | |
| SCHEMBL7982357 | 0.85 | BCHE (0.41) | SLC6A2SLC6A3ADRA1DADRA1AADRA1B | |
| SCHEMBL7976349 | 0.84 | KCNA3 (0.42) | SLC6A2SLC6A3 | |
| SCHEMBL7976352 | 0.84 | KCNA3 (0.42) | SLC6A2SLC6A3 | |
| SCHEMBL7982371 | 0.83 | CA1 (0.42) | — | |
| SCHEMBL7982369 | 0.83 | CA1 (0.42) | — | |
| SCHEMBL8196423 | 0.81 | MEN1 (0.38) | MGLLSLC6A2SLC6A3PRCPCARM1 | |
| SCHEMBL7982482 | 0.78 | DRD2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6255323-B1 | Cyanoguanidine compounds | SHIONOGI BIORESEARCH CORP. | 2001-07-03 | — | — | US | disclosed |